These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 32881954)

  • 1. Purified IgG from aquaporin-4 neuromyelitis optica spectrum disorder patients alters blood-brain barrier permeability.
    Cobo-Calvo A; Ruiz A; Richard C; Blondel S; Cavagna S; Strazielle N; Ghersi-Egea JF; Giraudon P; Marignier R
    PLoS One; 2020; 15(9):e0238301. PubMed ID: 32881954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autocrine MMP-2/9 secretion increases the BBB permeability in neuromyelitis optica.
    Tasaki A; Shimizu F; Sano Y; Fujisawa M; Takahashi T; Haruki H; Abe M; Koga M; Kanda T
    J Neurol Neurosurg Psychiatry; 2014 Apr; 85(4):419-30. PubMed ID: 24259591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuromyelitis optica study model based on chronic infusion of autoantibodies in rat cerebrospinal fluid.
    Marignier R; Ruiz A; Cavagna S; Nicole A; Watrin C; Touret M; Parrot S; Malleret G; Peyron C; Benetollo C; Auvergnon N; Vukusic S; Giraudon P
    J Neuroinflammation; 2016 May; 13(1):111. PubMed ID: 27193196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional consequences of neuromyelitis optica-IgG astrocyte interactions on blood-brain barrier permeability and granulocyte recruitment.
    Vincent T; Saikali P; Cayrol R; Roth AD; Bar-Or A; Prat A; Antel JP
    J Immunol; 2008 Oct; 181(8):5730-7. PubMed ID: 18832732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuromyelitis Optica Immunoglobulin G present in sera from neuromyelitis optica patients affects aquaporin-4 expression and water permeability of the astrocyte plasma membrane.
    Melamud L; Fernández JM; Rivarola V; Di Giusto G; Ford P; Villa A; Capurro C
    J Neurosci Res; 2012 Jun; 90(6):1240-8. PubMed ID: 22354518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuromyelitis optica spectrum disorder: Pathogenesis, treatment, and experimental models.
    Wu Y; Zhong L; Geng J
    Mult Scler Relat Disord; 2019 Jan; 27():412-418. PubMed ID: 30530071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucose-regulated protein 78 autoantibody associates with blood-brain barrier disruption in neuromyelitis optica.
    Shimizu F; Schaller KL; Owens GP; Cotleur AC; Kellner D; Takeshita Y; Obermeier B; Kryzer TJ; Sano Y; Kanda T; Lennon VA; Ransohoff RM; Bennett JL
    Sci Transl Med; 2017 Jul; 9(397):. PubMed ID: 28679661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intrastriatal injection of interleukin-1 beta triggers the formation of neuromyelitis optica-like lesions in NMO-IgG seropositive rats.
    Kitic M; Hochmeister S; Wimmer I; Bauer J; Misu T; Mader S; Reindl M; Fujihara K; Lassmann H; Bradl M
    Acta Neuropathol Commun; 2013 May; 1():5. PubMed ID: 24252536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [In vivo experimental models of neuromyelitis optica].
    Misu T
    Nihon Rinsho; 2014 Nov; 72(11):1941-8. PubMed ID: 25518375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective localization of IgG from cerebrospinal fluid to brain parenchyma.
    Mørch MT; Sørensen SF; Khorooshi R; Asgari N; Owens T
    J Neuroinflammation; 2018 Apr; 15(1):110. PubMed ID: 29665816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New BBB Model Reveals That IL-6 Blockade Suppressed the BBB Disorder, Preventing Onset of NMOSD.
    Takeshita Y; Fujikawa S; Serizawa K; Fujisawa M; Matsuo K; Nemoto J; Shimizu F; Sano Y; Tomizawa-Shinohara H; Miyake S; Ransohoff RM; Kanda T
    Neurol Neuroimmunol Neuroinflamm; 2021 Nov; 8(6):. PubMed ID: 34667128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Markedly increased IP-10 production by blood-brain barrier in neuromyelitis optica.
    Shimizu F; Nishihara H; Sano Y; Takeshita Y; Takahashi S; Maeda T; Takahashi T; Abe M; Koga M; Kanda T
    PLoS One; 2015; 10(3):e0122000. PubMed ID: 25811465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FTY720 Exacerbates Blood-Brain Barrier Dysfunction Induced by IgG Derived from Patients with NMO and MOG Disease.
    Yoshimura S; Nakagawa S; Takahashi T; Tanaka K; Tsujino A
    Neurotox Res; 2021 Aug; 39(4):1300-1309. PubMed ID: 33999356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Marked central nervous system pathology in CD59 knockout rats following passive transfer of Neuromyelitis optica immunoglobulin G.
    Yao X; Verkman AS
    Acta Neuropathol Commun; 2017 Feb; 5(1):15. PubMed ID: 28212662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experimental animal models of aquaporin-4-IgG-seropositive neuromyelitis optica spectrum disorders: progress and shortcomings.
    Duan T; Verkman AS
    Brain Pathol; 2020 Jan; 30(1):13-25. PubMed ID: 31587392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effector functions of antiaquaporin-4 autoantibodies in neuromyelitis optica.
    Cayrol R; Saikali P; Vincent T
    Ann N Y Acad Sci; 2009 Sep; 1173():478-86. PubMed ID: 19758189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Noninvasive, Targeted Creation of Neuromyelitis Optica Pathology in AQP4-IgG Seropositive Rats by Pulsed Focused Ultrasound.
    Yao X; Adams MS; Jones PD; Diederich CJ; Verkman AS
    J Neuropathol Exp Neurol; 2019 Jan; 78(1):47-56. PubMed ID: 30500945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severely exacerbated neuromyelitis optica rat model with extensive astrocytopathy by high affinity anti-aquaporin-4 monoclonal antibody.
    Kurosawa K; Misu T; Takai Y; Sato DK; Takahashi T; Abe Y; Iwanari H; Ogawa R; Nakashima I; Fujihara K; Hamakubo T; Yasui M; Aoki M
    Acta Neuropathol Commun; 2015 Dec; 3():82. PubMed ID: 26637322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuromyelitis optica pathology in rats following intraperitoneal injection of NMO-IgG and intracerebral needle injury.
    Asavapanumas N; Verkman AS
    Acta Neuropathol Commun; 2014 Apr; 2():48. PubMed ID: 24758159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unique neuromyelitis optica pathology produced in naïve rats by intracerebral administration of NMO-IgG.
    Asavapanumas N; Ratelade J; Verkman AS
    Acta Neuropathol; 2014 Apr; 127(4):539-51. PubMed ID: 24190619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.